Description
Today on MedNet21, we're going to discuss Prostate Cancer Screening.
This presentation will discuss what we have learned about PSA screening in the last 20 years. This includes the proposed benefits, harms, and national controversies. We will conclude with a practical approach to applying PSA screening in a primary care setting.
Dates and Times
End Date: 9/12/2022
Objectives
As a result of this educational activity, webcast participants will be able to: UNDERSTAND the
rationale, benefits, and harms of prostate cancer screening; and DEVELOP an approach for prostate cancer screening in a primary care setting.
You’ll also learn about the following:
- Prostate cancer risk factors
- The problem with the PSA
- False positive PSAs
- False negative PSAs
- Interpreting the PSA trajectory over time
- The urologist’s approach to an elevated PSA
- Common prostate cancer treatments and their complications
Webcasts Files
Webcasts Links
Title | Link |
---|---|
Listen to Audio Only CME Podcasts |
View Link |
Speakers
Accreditation
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.